LipoDerm-Y is the most significant breakthrough in fat loss products to date. Containing the alpha-2 receptor antagonist Yohimbine Hydrochloride in Avant Labs Patent Pending hydroalcoholic gel, Lipoderm-Y releases large amounts of fat from the site(s) of application - far higher than is possible with alternate administration methods - while avoiding the negative side effects associated with systematic distribution. Coupled with a caloric deficit, Lipoderm-Y's targeted delivery accelerates localized fat loss in those typically stubborn areas, such as a women's lower body or a mans midsection. Lipoderm-Y makes what was once the myth of spot reduction a scientifically proven reality. (These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.)
ترست بايلوت
منذ أسبوع
منذ شهرين